CHI3L1 and head and neck cancer: In particular, high serum YKL-40 identifies a subgroup of patients with head and neck cancer squamous cell carcinoma characterized by worse OS (HR = 1.55, p < 0.0001) and relapse-free survival (HR = 2.75, p = 0.01) (60).